Every patient with acute stroke who presents to a medical center that has a
ppropriate resources should undergo evaluation for intravenous tPA therapy.
Such therapy should not be given unless the patient meets strict eligibili
ty criteria based on clinical, radiographic, and laboratory data. Intra-art
erial thrombolysis may be a promising alternative to intravenous tPA therap
y, but it should still be regarded as experimental. Daily aspirin therapy s
hould be initiated immediately in most patients who do not receive intraven
ous tPA therapy and after 24 hours in most patients who receive this treatm
ent. Measures should be taken to prevent medical complications, such as asp
iration pneumonia, deep vein thrombosis, contractures, and pressure sores.
Early initiation of rehabilitation can maximize stroke recovery. Whenever f
easible, institutions should have stroke teams or units to streamline care
and provide expertise for patients with acute stroke.